United States · 
What does Samsara BioCapital invest in?
Samsara BioCapital invests most often at Series B and Series A (65% of the rounds on record), in sectors such as Biotech and Therapeutics.
Samsara BioCapital highlights
- 01
28 cheques in the last 12 months
- 02
Mostly Series B and Series A: 65% of its rounds
- 03
Sole investor in 4 rounds, median $59M
What they do
Investing to create transformative therapeutics for patients.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $1.0M – $100M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- BiotechTherapeutics
- Based in
- Palo Alto, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first103 appearances
- 2026
21 rounds
- Jul
- Jul
- Jul
- Jun
- Jun
- Jun
- Jun
- Jun
- May
- Apr
- Apr
- Apr
- Mar
- Mar
- Mar
- Feb
- Jan
- Jan
- Jan
- Jan
- Jan
- 2025
22 rounds
- Dec
- Dec
- Dec
- Dec
- Dec
- Nov
- Nov
- Oct
- Oct
- Sept
- Sept
- Sept
- Sept
- Aug
- Jul
- Jun
- Jun
- May
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
AAAbrar Ahmed HussainGeneral Counsel and Chief Compliance OfficeriForm ADV
MPMichael Philip DybbsManaging MemberiFiling they signed
MNMiran Nasruddin AhmadChief Financial OfficeriForm ADV
SASrinivas AkkarajuManager of Samsara Biocapital, LLCiForm ADV
We also hold 31 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$2.2Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Samsara Biocapital, LLC
- SEC number
- CRD 288114
Funds on its Form ADV
3 private funds, $1.7B in gross assets · filed Mar 2024
- Samsara BioCapital, L.P.Venture154 investors$1.6B
- SMSR B1, L.P.Venture1 investor$121M
- 565 SPV I, L.P.Venture8 investors$11K
What they claim to have backed
From their own portfolio page (on their website)
0 of 1 we have independently watched raise
Investor Portal
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.